Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 391 - 400 of 400

Selected Filters:
1 August 2017

Assessment of Opportunities to Deliver Oral PrEP for Women Through Private Sector Health Care: South Africa research findings

The objective of this research is to support planning by the South African government, international donors, and implementing agencies by providing an overview of the opportunities and considerations for delivering oral PrEP to women through the private sector. This analysis is focused on the delivery of oral PrEP and does not include other areas of…

Financing & Costing, Research, Monitoring & Evaluation

Document
1 August 2017

Assessment of Opportunities to Deliver Oral PrEP for Women Through Private Sector Health Care: Kenya research findings

The objective of this research is to support planning by the Kenyan government, international donors, and implementing agencies by providing an overview of the opportunities and considerations for delivering oral PrEP to women through the private sector. This analysis is focused on the delivery of oral PrEP and does not include other areas of potential…

Financing & Costing, Research, Monitoring & Evaluation

Document
1 August 2017

Assessment of Opportunities to Deliver Oral PrEP for Women Through Private Sector Health Care: Summary of research findings

The objective of this research is to support planning by country governments, international donors, and implementing agencies by providing an overview of the opportunities and considerations for delivering oral PrEP to women through the private sector. This analysis is focused on the delivery of oral PrEP and does not include other areas of potential private…

Financing & Costing, Research, Monitoring & Evaluation

Document
1 August 2017

Assessment of Opportunities to Deliver Oral PrEP for Women Through Private Sector Health Care: Zimbabwe research findings

The objective of this research is to support planning by the Zimbabwean government, international donors and implementing agencies by providing an overview of the opportunities and considerations for delivering oral PrEP to women through the private sector. This analysis is focused on the delivery of oral PrEP and does not include other areas of potential…

Financing & Costing, Research, Monitoring & Evaluation

Document
1 April 2017

Modelling Literature Review Bibliography

Modeling studies of the impact of microbicides between 2008-2016

Research

Document
1 April 2017

Dapivirine Ring Modeling Literature Review

A 2017 report on the results of a review of studies on the dapivirine vaginal ring (the PrEP Ring) and microbicide modelling.

Financing & Costing, Research

Document
6 March 2016

MTN-003B

Archived from the MTN website before it was taken down. Primary Objective Compare changes in Bone Mineral Density (BMD) after one year among VOICE participants receiving oral tenofovir disoproxil fumarate (tenofovir or TDF) and emtricitabine (FTC)/TDF (Truvada) compared with oral placebo Study Summary The BMD Substudy was an observational substudy of VOICE designed to assess…

Research

3 June 2015

MTN-017

Archived from the MTN website before it was taken down. Primary Objectives Compare the safety profiles of Truvada®, daily RG tenofovir 1% gel, and receptive anal intercourse (RAI)-associated RG tenofovir 1% gel Evaluate and compare acceptability of Truvada, daily RG tenofovir 1% gel, and RAI-associated RG tenofovir 1% gel Study Summary MTN-017 was a Phase…

Research

15 February 2015

MTN-003 VOICE

Archived from the MTN website before it was taken down. Primary Objectives Estimate the effectiveness of daily tenofovir 1% gel compared to a vaginal placebo gel, and the effectiveness of oral TDF and oral FTC/TDF compared to an oral placebo in preventing HIV infection among women at risk for sexually transmitted infection (STI) Evaluate the…

Research

21 February 2014

MTN-003C

Archived from the MTN website before it was taken down. Primary Objectives Explore socio-cultural and contextual factors that participants identify as influencing product use (and non-use) in VOICE Determine if factors identified by participants as influencing product use (and non-use) are different between those who are randomized to the vaginal product arm vs. oral product…

Research